In conclusion we believe that general practitioners and neuroophthalmologists should recommend against the use of PDE inhibitors not only in patients who have already experienced an episode of NAION in one eye, as stated by the European Supplementary Protection Certificate class labelling, or have a small disc-at-risk, but also in patients with predisposing systemic vascular diseases like hypertension or diabetes.
Case Report Med. 2012; 2012: 747658.
Published online 2012 March 19. doi: 10.1155/2012/747658
A Study to #$%$ Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
This study has been completed.
Information provided by (Responsible Party):